SciBase secures first payer coverage with Highmark, marking a major commercial inflection point
STOCKHOLM, October 14, 2026 /PRNewswire/ --SciBase Holding AB ("SciBase") (STO: SCIB) a leader in advanced technology for the detection and prevention ofskin disease, announced today that Nevisense has received its first positive medical policy from Highmark Blue Cross Blue Shield, one of...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.